CompanyGraphAt a glance
- Depends onUpstream position: supplies 9 industries, depends on 0
- FinancialsAltman Z-Score 3.18: safe zone
- Interpretations4 currently firing — 4
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
6.65%Below 5Y avg (7.06%)
Annual Rate
TRY 103.00Paid annual
Payout Ratio
108.7%High
Payback Period
14.0 yr
Last Ex-Dividend
Apr 24, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
37.64BTRY790.91M · vs all stocks (USD)
Trailing P/E
11.32xRevenue (TTM)
19.49BTRY409.52M · vs all stocks (USD)
Profit Margin
16.15%Beta
-0.3710xvs all stocks
52-Week Change
-7.47%vs all stocks
Market Capitalization
37.64BTRY790.91M · vs all stocks (USD)
Enterprise Value
45.39BTRY953.81M · vs all stocks (USD)
Trailing P/E
11.32xForward P/E
165.41xPEG Ratio
-0.1149xPrice to Sales (TTM)
1.91xPrice to Book (MRQ)
4.57xEnterprise to Revenue
2.33xEnterprise to EBITDA
9.30xGross Margin
25.17%Profit Margin
16.15%Operating Margin
8.24%Return on Assets (TTM)
11.10%Return on Equity (TTM)
37.54%Revenue (TTM)
19.49BTRY409.52M · vs all stocks (USD)
Revenue per Share (TTM)
802.06TRYUpdated Jul 16, 2026Quarterly Revenue Growth
38.00%Gross Profit (TTM)
6.55BTRY137.56M · vs all stocks (USD)
EBITDA (TTM)
5.03BTRY105.70M · vs all stocks (USD)
Net Income (TTM)
3.52BTRY73.97M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-98.70%Operating Cash Flow (TTM)
3.38BTRY71.08M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-599.83MTRY-12.60M · vs all stocks (USD)
Trailing Annual Dividend Rate
103.00TRYUpdated Jul 16, 2026Trailing Annual Dividend Yield
6.65%vs all stocks
5-Year Average Dividend Yield
7.06%vs all stocks
Payout Ratio
108.70%Minority Interest (Equity)
1.00BTRYFY2025 · Dec 31, 2025Revenue
18.23BTRYFY2025 · Dec 31, 2025Cost of Goods Sold
11.95BTRYFY2025 · Dec 31, 2025Gross Profit
6.28BTRYFY2025 · Dec 31, 2025Operating Income
4.15BTRY87.19M · vs all stocks (USD)
Pre-tax Income
3.83BTRYFY2025 · Dec 31, 2025Income Tax Expense
378.88MTRYFY2025 · Dec 31, 2025Net Income
3.72BTRYFY2025 · Dec 31, 2025EBIT
4.31BTRYFY2025 · Dec 31, 2025EBITDA (Income Statement)
5.37BTRYFY2025 · Dec 31, 2025Selling, General & Administrative
1.04BTRYFY2025 · Dec 31, 2025Other Operating Expenses
515.83MTRYFY2025 · Dec 31, 2025Non-operating Interest Income
271.13MTRYFY2025 · Dec 31, 2025Non-operating Interest Expense
486.03MTRYFY2025 · Dec 31, 2025Net Income from Continuing Operations
3.72BTRYFY2025 · Dec 31, 2025Minority Interests (P&L)
-86.90MTRYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00TRYFY2025 · Dec 31, 2025Operating Cash Flow
1.98BTRYFY2025 · Dec 31, 2025Free Cash Flow
-400.16MTRYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
3.73BTRYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
3.72BTRYFY2025 · Dec 31, 2025Other Non-cash Items
221.47MTRYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-1.05BTRYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-915.63MTRYFY2025 · Dec 31, 2025Capital Expenditures
-2.38BTRYFY2025 · Dec 31, 2025Net Intangibles (CF)
-65.50MTRYFY2025 · Dec 31, 2025Net Acquisitions
-1.63BTRYFY2025 · Dec 31, 2025Other Investing Activity
-208.92MTRYFY2025 · Dec 31, 2025Net Investing Cash Flow
-4.22BTRYFY2025 · Dec 31, 2025Long-term Debt Issuance
3.29BTRYFY2025 · Dec 31, 2025Long-term Debt Payments
-2.27BTRYFY2025 · Dec 31, 2025Common Dividends Paid
-3.58BTRYFY2025 · Dec 31, 2025Other Financing Charges
-334.86MTRYFY2025 · Dec 31, 2025Net Financing Cash Flow
-2.90BTRYFY2025 · Dec 31, 2025Shares Outstanding
24.30MSharesUpdated Jul 16, 2026% Held by Insiders
89.91%vs all stocks
% Held by Institutions
0.72%vs all stocks
Total Cash (MRQ)
4.55BTRY95.58M · vs all stocks (USD)
Total Cash per Share (MRQ)
187.20TRYUpdated Jul 16, 2026Total Debt (MRQ)
11.05BTRY232.14M · vs all stocks (USD)
Total Debt to Equity (MRQ)
1.20xCurrent Ratio (MRQ)
1.26xBook Value per Share (MRQ)
335.95TRYUpdated Jul 16, 2026Total Assets
24.45BTRY513.83M · vs all stocks (USD)
Total Current Assets
10.03BTRYFY2025 · Dec 31, 2025Total Liabilities
15.06BTRYFY2025 · Dec 31, 2025Total Non-current Assets
14.42BTRYFY2025 · Dec 31, 2025Total Non-current Liabilities
7.71BTRYFY2025 · Dec 31, 2025Total Current Liabilities
7.34BTRYFY2025 · Dec 31, 2025Cash
693.64MTRYFY2025 · Dec 31, 2025Cash Equivalents
3.08BTRYFY2025 · Dec 31, 2025Cash & Cash Equivalents
3.77BTRYFY2025 · Dec 31, 2025Other Short-term Investments
39.14MTRYFY2025 · Dec 31, 2025Accounts Receivable
2.11BTRYFY2025 · Dec 31, 2025Inventory
229.82MTRYFY2025 · Dec 31, 2025Accounts Payable
1.19BTRYFY2025 · Dec 31, 2025Short-term Debt
3.45BTRYFY2025 · Dec 31, 2025Other Current Liabilities
10.14MTRYFY2025 · Dec 31, 2025Long-term Debt
7.26BTRYFY2025 · Dec 31, 2025Common Stock (Book)
24.30MTRYFY2025 · Dec 31, 2025Retained Earnings
3.91BTRYFY2025 · Dec 31, 2025Total Shareholders' Equity
9.40BTRY197.41M · vs all stocks (USD)
52-Week Low
1.44KTRYUpdated Jul 16, 202652-Week High
2.25KTRYUpdated Jul 16, 202652-Week Change
-7.47%vs all stocks
Beta
-0.3710xvs all stocks
50-Day MA
1.66KTRYUpdated Jul 16, 2026200-Day MA
1.69KTRYUpdated Jul 16, 2026Avg 10-Day Volume
33.65KSharesUpdated Jul 16, 2026Avg 30-Day Volume
33.99KSharesUpdated Jul 16, 2026Diluted EPS (TTM)
135.63TRYUpdated Jul 16, 20264 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Industry-Benchmarked Return on Capital Elevated
It earns more on its assets and its equity than its industry, and gets more sales from those assets.
Reads
ROE, ROA, And Operating ROA Elevated
It earns more on its equity than its industry does, and on its assets too — not on borrowing alone.
Reads
Minimal Tax and Interest Drag
Almost nothing is lost between its operating profit and its net income.
Reads
How is this stock valued?
Price Below Mean With Profitability And Book Value
Price sits well below its yearly mean, on three profitable years and rising book value.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.18: safe zoneNotable
Altman Z-Score: 3.18
Supply Chain
Upstream position: supplies 9 industries, depends on 0Notable
Outgoing: 9.00Incoming: 0.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Jilin Expressway Co., Ltd.
Tier 1FlowRegulated Return InfrastructureProductionRule
Hubei Chutian Smart Communication Co., Ltd.
Tier 1FlowRegulated Return InfrastructureProductionSenseMaking
China Resources and Environment Co., Ltd.
Tier 1FlowRegulated Return InfrastructureRuleProduction
Anhui Zhonghuan Environment Protection Co., Ltd.
Tier 1FlowRegulated Return InfrastructureRuleProduction
Ecorodovias Infraestrutura e Logística S.A.
Tier 1FlowRegulated Return InfrastructureProductionRule
Shenzhen Investment Holdings Bay Area Development Company Limited
Tier 1FlowRegulated Return InfrastructureProductionRisk
Beijing Water Business Doctor Co., Ltd.
Tier 1FlowRegulated Return InfrastructureProductionRule
Bestsun Energy Co., Ltd.
Tier 1FlowRegulated Return InfrastructureRuleProduction
Cecep Guozhen Environmental Protection Technology Co., Ltd.
Tier 1FlowRegulated Return InfrastructureRuleProduction
Xiamen International Airport Co., Ltd.
Tier 1FlowRegulated Return InfrastructureProductionInterface
Companies that share active interpretations — structural patterns currently present in both stocks.
Sk Biopharmaceuticals Co., Ltd.
3 interpretationsMinimal Tax and Interest DragROE, ROA, And Operating ROA ElevatedIndustry-Benchmarked Return on Capital Elevated
Kalekim Kimyevi Maddeler Sanayi ve Ticaret A.Ş.
3 interpretationsROE, ROA, And Operating ROA ElevatedIndustry-Benchmarked Return on Capital ElevatedPrice Below Mean With Profitability And Book Value
Xiamen Amoytop Biotech Co., Ltd.
3 interpretationsROE, ROA, And Operating ROA ElevatedIndustry-Benchmarked Return on Capital ElevatedPrice Below Mean With Profitability And Book Value